Portrait Founded in 2004 in Bergamo (Italy), ADIENNE Pharma & Biotech is an integrated pharmaceutical company dedicated to the treatment of rare and severe diseases.
ADIENNE has built a close collaboration with university and hospital teams to develop drugs from research to commercialization.
Because of its excellent and fast results achieved in the regulatory process and in commercializing its products ADIENNE is mainly interested in that kind of research effectively supplying the market.
The therapy-focused company target is dominated by haemato-oncology, HSCT, solid organ transplantation and autoimmune diseases, which represent the leading aims of R&D collaborations and licensing deals.
ADIENNE strengthens its activity on onco-hematology and on niche drug development by using its own operative structures.
Top
Contact
Print version
PDF version
Recommend company
